Identifying predictors of COVID-related delays in cancer-specific medical care.
Breanna B GretemanNatalie J Del VecchioCrystal J Garcia-AugusteAmanda R KahlBrian M GryzlakElizabeth A ChrischillesMary E CharltonSarah H NashPublished in: Cancer medicine (2024)
These findings may inform cancer care delivery during periods of instability when treatment may be disrupted by informing clinicians about concerns that patients have during the treatment process. Future research should assess whether delays in cancer care impact long-term cancer outcomes and whether delays exacerbate existing disparities in cancer outcomes.
Keyphrases
- papillary thyroid
- squamous cell
- coronavirus disease
- end stage renal disease
- sars cov
- ejection fraction
- type diabetes
- healthcare
- lymph node metastasis
- metabolic syndrome
- young adults
- adipose tissue
- combination therapy
- peritoneal dialysis
- skeletal muscle
- current status
- insulin resistance
- patient reported outcomes
- glycemic control